+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy, Surgery), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Achilles Tendonitis), By Region (North America, Europe), And Segment Forecasts, 2025 - 2030- Product Image
Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy, Surgery), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Achilles Tendonitis), By Region (North America, Europe), And Segment Forecasts, 2025 - 2030- Product Image
New

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy, Surgery), By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Achilles Tendonitis), By Region (North America, Europe), And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • November 2024
  • Region: Global
  • Grand View Research
  • ID: 5440484
Description Jump to:
The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.1% from 2025 to 2030. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.

Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children’s Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.

During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.

The Achilles tendonitis segment dominated the industry in 2022. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2022 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.

Tendonitis Treatment Market Report Highlights

  • By treatment, the therapy segment dominated the tendonitis treatment industry with the largest revenue share in 2024. The increasing preference of patients with tendonitis for non-invasive treatments contributes to segment growth.
  • By condition, the Achilles tendonitis segment dominated the market with a revenue share of 48.8% in 2024. The segment dominated the market due to the high incidence of Achilles tendonitis condition, particularly among athletes and individuals engaged in repetitive physical activities.
  • North America tendonitis treatment market dominated with a revenue share of 42.2% in 2024. A growing number of surgeries performed for tendonitis in the region and increasing consumer disposable income levels are among the few factors that contribute to the region’s growth.
  • The Asia Pacific region is expected to witness the fastest growth in the tendonitis treatment market over the forecast period, driven by a combination of factors such as a large and rapidly aging population, increased awareness about musculoskeletal health, and rising healthcare investments.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Condition outlook
2.2.2. Treatment outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Tendonitis Treatment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Regulatory Framework
3.4. Tendonitis Treatment: Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PESTLE Analysis
Chapter 4. Tendonitis Treatment Market Segment Analysis, By Treatment, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Treatment Market Share Analysis, 2024 & 2030
4.3. Segment Dashboard
4.4. Global Tendonitis Treatment Market, by Treatment, 2018 to 2030
4.5. Therapy
4.5.1. Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Hot and Cold Therapy
4.5.2.1. Hot and Cold Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Physical Therapy
4.5.3.1. Physical therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.4. Shockwave Therapy
4.5.4.1. Shockwave Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Surgery
4.6.1. Surgery market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Tendonitis Treatment Market Segment Analysis, By Condition, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Condition Market Share Analysis, 2024 & 2030
5.3. Segment Dashboard
5.4. Global Tendonitis Treatment Market, by Condition, 2018 to 2030
5.5. Tennis elbow
5.5.1. Tennis elbow market estimates and forecasts, 2018 to 2030 (USD million)
5.6. Golfer’s elbow
5.6.1. Golfer’s elbow market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Pitcher’s elbow
5.7.1. Pitcher’s elbow market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Jumper’s Knee
5.8.1. Jumper’s Knee market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Swimmer’s shoulder
5.9.1. Swimmer’s shoulder market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Achilles Tendonitis
5.10.1. Achilles tendonitis market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Tendonitis Treatment Market Segment Analysis, By Region, 2018- 2030 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2030
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Tendonitis Treatment Market Share by Region, 2024 & 2030:
6.5. North America
6.5.1. North America tendonitis treatment market, 2018 - 2030 (USD Million)
6.5.2. U.S.
6.5.2.1. U.S. tendonitis treatment market, 2018 - 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Canada tendonitis treatment market, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Mexico tendonitis treatment market, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. Europe tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.2. UK
6.6.2.1. UK tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Germany tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.4. France
6.6.4.1. France tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Italy tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Spain tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.7. Norway
6.6.7.1. Norway tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Sweden tendonitis treatment market, 2018 - 2030 (USD Million)
6.6.9. Denmark
6.6.9.1. Denmark tendonitis treatment market, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Japan tendonitis treatment market, 2018 - 2030 (USD Million)
6.7.2. China
6.7.2.1. China tendonitis treatment market, 2018 - 2030 (USD Million)
6.7.3. India
6.7.3.1. India tendonitis treatment market, 2018 - 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Australia tendonitis treatment market, 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. South Korea tendonitis treatment market, 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Thailand tendonitis treatment market, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Brazil tendonitis treatment market, 2018 - 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Argentina tendonitis treatment market, 2018 - 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. South Africa tendonitis treatment market, 2018 - 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Saudi Arabia tendonitis treatment market, 2018 - 2030 (USD Million)
6.9.3. UAE
6.9.3.1. UAE tendonitis treatment market, 2018 - 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Kuwait tendonitis treatment market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Merck and Co., Inc.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Bayer AG
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. AstraZeneca
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Boehringer Ingelheim Pharmaceuticals, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Pfizer
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. GlaxoSmithKline PLC
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Almatica Pharma, Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Teva Pharmaceuticals Industries
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. Product pipeline/clinical stage
Table 4. List of emerging companies in tendonitis treatment market
Table 5. North America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
Table 6. North America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 7. North America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 8. U.S. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 9. U.S. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 10. Canada Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 11. Canada Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 12. Mexico Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 13. Mexico Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 14. Europe Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
Table 15. Europe Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 16. Europe Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 17. U.K. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 18. U.K. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 19. Germany Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 20. Germany Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 21. France Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 22. France Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 23. Spain Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 24. Spain Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 25. Italy Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 26. Italy Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 27. Norway Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 28. Norway Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 29. Denmark Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 30. Denmark Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 31. Sweden Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 32. Sweden Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 33. Asia Pacific Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
Table 34. Asia Pacific Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 35. Asia Pacific Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 36. China Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 37. China Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 38. Japan Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 39. Japan Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 40. India Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 41. India Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 42. Australia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 43. Australia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 44. South Korea Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 45. South Korea Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 46. Thailand Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 47. Thailand Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 48. Latin America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
Table 49. Latin America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 50. Latin America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million
Table 51. Brazil Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 52. Brazil Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 53. Argentina Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 54. Argentina Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 55. MEA Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
Table 56. MEA Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 57. MEA Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 58. South Africa Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 59. South Africa Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 60. Saudi Arabia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 61. Saudi Arabia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 62. UAE Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 63. UAE Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
Table 64. Kuwait Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
Table 65. Kuwait Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity Flow Analysis
Fig. 9 Volume Price Analysis
Fig. 10 Tendonitis Treatment Market snapshot (2022)
Fig. 11 Tendonitis Treatment Market segmentation
Fig. 12 Market trends and outlook
Fig. 13 Parent market outlook
Fig. 14 Related/ancillary market outlook
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 Tendonitis Treatment Market, treatment outlook: key takeaways (USD Million)
Fig. 18 Tendonitis Treatment Market: treatment movement analysis, 2022 & 2030 (USD Million)
Fig. 19 Therapy Treatment Market 2018 - 2030 (USD Million)
Fig. 20 Hot and Cold Treatment Market 2018 - 2030 (USD Million)
Fig. 21 Physical Therapy Treatment Market 2018 - 2030 (USD Million)
Fig. 22 Shockwave Therapy Treatment Market 2018 - 2030 (USD Million)
Fig. 23 Surgery Treatment Market 2018 - 2030 (USD Million)
Fig. 24 Tendonitis Treatment Market, Condition outlook: key takeaways (USD Million)
Fig. 25 Tendonitis Treatment Market: Condition movement analysis, 2022 & 2030 (USD Million)
Fig. 26 Tennis Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Golfer’s Elbow market estimates and forecasts, 2018 - 2030 (USD Million
Fig. 28 Pitcher’s Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Jumper’s Knee market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Swimmer’s Shoulder market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Achilles Tendonitis market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Tendonitis Treatment Market, regional marketplace: Key takeaways (USD Million)
Fig. 33 Tendonitis Treatment Market: regional movement analysis, 2022 & 2030 (USD Million)
Fig. 34 North America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.S. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Canada Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Mexico Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Europe Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Germany Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 U.K. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 France Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Spain Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Italy Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Sweden Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Denmark Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Norway Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Asia Pacific Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Japan Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 China Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 India Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Australia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 South Korea Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Latin America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Brazil Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Argentina Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 MEA Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 South Africa Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Saudi Arabia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 UAE Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Kuwait Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Merck and Co., Inc.
  • Bayer AG
  • AstraZeneca
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Abbott
  • Pfizer
  • GlaxoSmithKline PLC
  • Almatica Pharma, Inc.
  • Teva Pharmaceuticals Industries

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 232.02 Billion
Forecasted Market Value ( USD ) by 2030 $ 281.8 Billion
Compound Annual Growth Rate3.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Tendonitis Treatment Global Market Report 2024 - Product Image

Tendonitis Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Tendonitis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Tendonitis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Tendonitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Tendonitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 139 Pages
  • Global
From
Tendinitis Treatment - Global Strategic Business Report - Product Image

Tendinitis Treatment - Global Strategic Business Report

  • Report
  • 390 Pages
  • Global
From
Prolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Prolotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 185 Pages
  • Global
From

About the Tendonitis Drug Market

The Tendonitis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. It is composed of drugs used to treat tendonitis, a condition characterized by inflammation of the tendons. Common treatments include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and physical therapy. In some cases, surgery may be necessary. The Musculoskeletal Disorders Drugs market is a large and growing market, driven by an aging population and increasing prevalence of musculoskeletal disorders. The market is expected to continue to grow in the coming years, driven by the increasing prevalence of musculoskeletal disorders and the development of new treatments. Some of the major players in the Tendonitis Drug market include Pfizer, Merck, Novartis, Johnson & Johnson, and Eli Lilly. Other companies in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.